Ares Genetics GmbH

About:

Ares Genetics develops Artificial Intelligence informed DNA-Sequencing Tests to revolutionize Infectious Disease and Drug Resistance Testing

Website: http://www.ares-genetics.com

Top Investors: Vienna Business Agency

Description:

OpGen uses molecular microbiology and bioinformatics to create diagnostic solutions that will improve the treatment of life-threatening, drug-resistant infections. By employing precision medicine to guide antibiotic therapy selection and aid enhance antibiotic stewardship, the business hopes to drastically revolutionize patient care.

Total Funding Amount:

1.3M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vienna, Wien, Austria

Founded Date:

2017-01-01

Contact Email:

contact(AT)ares-genetics.com

Founders:

Arne Materna

Number of Employees:

11-50

Last Funding Date:

2019-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai